Schroder Investment Management Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.27M | Sell |
554,958
-313,053
| -36% | -$3.54M | 0.01% | 730 |
|
|
2025
Q1 | $10.4M | Buy |
868,011
+62,566
| +8% | +$746K | 0.01% | 634 |
|
|
2024
Q4 | $6.76M | Buy |
805,445
+374,213
| +87% | +$3.14M | 0.01% | 719 |
|
|
2024
Q3 | $5.32M | Sell |
431,232
-36,766
| -8% | -$454K | 0.01% | 775 |
|
|
2024
Q2 | $5.51M | Buy |
467,998
+213,224
| +84% | +$2.51M | 0.01% | 761 |
|
|
2024
Q1 | $3.02M | Buy |
+254,774
| New | +$3.02M | ﹤0.01% | 866 |
|